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Summary Radioprotection of spheroids of Chinese hamster V79 cells by WR-2721 was found to be a
function of spheroid size, with the greatest dose-modifying effect by the protector observed for spheroids
almost large enough to contain radioresistant "anoxic" cells. The nature of the response suggested that most
of the protective effect was due to the presence of an increased hypoxic fraction in the drug-treated spheroids.
Similarly, when single-cell suspensions were irradiated at various oxygen tensions, one component of
radioprotection by WR-2721 was found to be highly dependent upon the available oxygen. Two mechanisms
of radioprotection of V79 cells by WR-2721 were thus demonstrated: a modest, oxygen-independent effect,
presumably due to hydrogen donation, and an oxygen-depleting effect, which is of maximal significance for
cells or tissues which would otherwise be partially sensitized by low levels of oxygen.
The radioprotective effects of S-2-(3-
aminopropylamino) ethylphosphorothioic acid
(WR-2721) have stimulated considerable recent
interest in both mechanistic studies of
radioprotectors, and potential clinical applicability
due to some reports of preferential radioprotection
of normal compared to malignant tissues (reviewed
by Phillips, 1980 and Yuhas, 1982). Mechanistic
studies have been complicated, however, by the
apparent need for dephosphorylation ("activation")
of the compound (Kollman et al., 1973, and
reviewed by Yuhas, 1982), lack of uptake by certain
cells (Yuhas, 1980) and lack of a quick, convenient,
and specific assay for the parent and
dephosphorylated forms of the drug in vivo and in
vitro. Most pharmacological studies have used
radioactive forms of the drug (Ritter et al., 1982),
Utley et al., 1976); these have, perhaps surprisingly,
indicated some drug uptake in most types of
mammalian cells or mammalian cell spheroids in
vitro (Ritter et al., 1982), despite the fact that
substantial radioprotection in vitro is not generally
observed (Vos et al., 1976), Purdie, 1979; Ritter et
al., 1982).
Based on the expectation that some degree of
uptake and dephosphorylation might occur in V79
spheroids in culture, and on the fact that those free
thiols produced within the cells would likely be
oxidized to disulfides (an oxygen-depleting process),
we undertook a study of the radio-protective effects
of WR-2721 in V79 cells having a compromised
oxygen supply, i.e., cells of V79 spheroids, or cell
suspensions equilibrated with a reduced-oxygen
atmosphere.
Materials and methods
Chinese hamster V79-171 cells were used
exclusively for these studies. Monolayers were
maintained with bi-weekly subcultivation using
Eagle's minimal essential medium (MEM)
purchased from Gibco, supplemented with 10%
foetal bovine serum (FBS) (Sterile Systems Inc.).
Spheroid growth, irradiation, and survival assays
utilized techniques identical to those previously
described (Sutherland & Durand, 1976; Durand,
1980); WR-2721 was freshly prepared and added to
spheroid flasks 15min prior to irradiation.
To ensure equilibration with the overlying
atmosphere, all single cell irradiations were
performed in rapidly-stirred single cell suspensions.
Custom-made waterjacketed spinner flasks similar
to those commercially available from Bellco were
maintained at 37°C, and were designed with a
reduced air volume to minimize equilibration times.
For drug exposure and irradiation, single cells were
suspended at a density of 5 x 105 cells ml-' using
Joklik-modified MEM (calcium- and magnesium-
free) and 5% FBS to minimize clumping. The
atmosphere above the cells was created by mixing
air, C02, and oxygen-free nitrogen (Matheson) in
the appropriate proportions in a stainless steel and
glass manifold system; the oxygen concentration in
the effluent gas from the irradiation vessel was
continuously monitored using a gas phase oxygen
analyzer (Applied Electrochemistry).
All irradiations were carried out using a J.L.
Shepherd and Associates Mark-i cesium irradiator.
Our protocol utilized a single cell suspension
prepared at the appropriate cell density, then placed
in the waterjacketed irradiation vessel where
temperature and atmosphere was monitored. Once
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equilibrated, the cells were incubated a further
30min at the desired oxygen concentration. WR-
2721 was then dissolved in serum-free MEM,
rapidly equilibrated to the same oxygen tension by
bubbling the desired gas mixture through the drug
solution, and then added to the irradiation vessel
and incubated for a further 15min prior to
irradiation. Following exposure at 6.2Gymin ' the
cells were centrifuged to remove excess WR-2721,
resuspended in complete medium, and appropriate
aliquots of cells plated for survival assay by colony
formation. No decreases in cloning efficiency due to
these short-term WR-2721 exposures were noted in
any experiments.
WR-2721 was generously supplied by the Drug
Synthesis Branch of the NCI; during the course of
these experiments, lots H-4 and AJ-68.4 were used.
Results
Radioprotection of V79 spheroids by WR-2721 was
found to be a critical function of spheroid size.
Typical results for the most interesting sizes, large
spheroids containing a hypoxic cell population, and
smaller spheroids almost large enough to show
radioresistant hypoxic cells, are indicated in Figure
1. Both drug-treated spheroid populations showed
enhanced high-dose survival (i.e., a radioresistant
tail); in the larger spheroids (Figure la), increasing
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(non-toxic) drug concentrations led to progressive
increases in the "extrapolation number" of the
resistant subpopulation (n=1.6 at 3mgml-1 vs. 0.7
for the control), with only a modest change in the
Do of the curves (DO=6.26Gy for 3mgml-' vs.
5.23 Gy for the controls). These results thus
suggested an increasing fraction of hypoxic cells
present in the drug-treated spheroids. In contrast, in
smaller spheroids where the control survival curve
showed only a single component (Do= 1.91 Gy),
addition of WR-2721 led to two-component
survival curves (Figure lb) suggesting that only a
subpopulation of the cells was protected. A
significantly greater resistance was noted for this
protected population in small spheroids irradiated
in 3mgml-1 WR-2721 (DO=4.86Gy), though this
value was not significantly different from that
observed for the hypoxic cell populations in the
larger spheroids. In spheroids smaller than those
shown in Figure 1, less protection was observed
(like the results for single cells presented in Figure
2a).
In agreement with many previous reports (Vos et
al., 1976, Purdie, 1979, Ritter et al., 1982), we found
only modest radioprotection of single cells by WR-
2721 under either aerobic or extreme hypoxic
(<30ppm 02) conditions (Figure 2). However,
when the cells were equilibrated with 1% oxygen
(Figure 2b), radioprotection was clearly a function
of the concentration of WR-2721 added. In Figure
b
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Figure 1 Modification of the radiation survival of Chinese hamster V79 cells grown and exposed as
spheroids. WR-2721 was added 15min prior to irradiation, at concentrations of 0.3mgml 1 (OI), 1.Omgml -
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Figure 2 Radioprotection of single cells in suspension by WR-2721 as a function of oxygen tension.
Protector concentrations of 3.Omgml-' (a), 1.Omgml-P (A), 0.3mgmlPl (l) and O.1mgml-1 (A\) are
compared with controls (0) in all panels; no drug-induced toxicity was noted for any of the concentrations of
WR-2721. In panels a, c, and d, complete curves are drawn only for the extreme responses: control cells, and
cells irradiated in 3.0mgml - I WR-2721.
2c, where the cells were equilibrated with 0.5%
oxygen, cellular radiation response in the presence
of all concentrations of WR-2721 was identical to
that observed for hypoxic cells with the same drug
concentration. In all cases, the survival curves
obtained in the drug-treated single cells suggested
that the agent acted in a strict "dose-modifying"
manner, i.e., no significant effects on the
extrapolation number of the survival curves were
noted.
Some of the data presented in Figure 2, and
additional data obtained at other oxygen
concentrations are plotted in a different format in
Figure 3. In panel 3a, the cellular radioresistance is
expressed as the Do of the observed survival curves,
and is plotted as a function of oxygen tension and
WR-2721 concentration. Increasing concentrations
of WR-2721 produced qualitatively similar
responses at increased oxygen tensions, as though
the WR-2721 was lowering the intracellular oxygen
concentration. As indicated in the lower panel of
Figure 3, the dose modifying or protection factor
observed for the different concentrations of WR-
2721 was very dependent on oxygen tension, and
was maximal for oxygen tensions just great enough
to provide radiosensitization in cell suspensions not
exposed to WR-2721. The fact that modest (and
essentially equal) radioprotection was observed for390 R.E. DURAND
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Figure 3 Radioprotection of single cells in suspension
by WR-2721; symbols for the drug concentrations used
are identical to those in Figures 1 and 2. In panel (a),
radioresistance is plotted as a function of oxygen
concentration above the medium; in panel (b), the
protection factor (ratio of the Do of the drug-treated
survival curve to that for the control) is similarly
depicted.
well-oxygenated or severely hypoxic cells suggests
that WR-2721 did show some oxygen-independent
radioprotection as well, probably through radical
scavenging and/or hydrogen donation reactions.
Discussion
The data presented here suggest that WR-2721
protects against radiation by two mechanisms:
radical scavenging and/or hydrogen donation
(which is independent of oxygen tension), and an
oxygen dependent mechanism that is critical in
those cells which are bordering upon being
radioresistant due to hypoxia. At least three
possibilities seem apparent for the latter mechanism:
1) WR-2721 dephosphorylation or "activation" rates
may be oxygen dependent, 2) radical scavenging
and/or hydrogen donation reactions may be more
efficient when trace levels of oxygen are present,
and/or 3) WR-2721 acts by an oxygen-depleting
mechanism. We favour the latter explanation, and
indeed, our data imply that the greatest part of the
potential radioprotection by WR-2721 may be a
"secondary" effect related to enhanced oxygen
removal and induction of hypoxia. The identical
conclusion was reached by Purdie et al. (1982),
using an experimental approach based on the rate
of oxygen utilization in human cells exposed to
WR-2721. We also have measured changes in the
respiration rate of V79 cells as a function of WR-
2721 concentration; in all cases, we found only a
modest stimulation of oxygen utilization by 10-20%
(data not shown), a much less dramatic response
than that reported by Purdie et al. (1982).
Presumably, this may be due, in part, to different
rates of drug uptake or dephosphorylation in our
conditions relative to those for the human cell line.
Support for this speculation follows from our
observation of 20-50% increases in oxygen
consumption when WR-2721 was dissolved in
medium at lower pH to promote dephosphorylation
(Purdie, 1980; Yuhas, 1982), or increases in oxygen
consumption rates by > 100% when 5PM reduced
glutathione was added to the cell suspensions (data
not shown).
Acceptance of the hypothesis that WR-2721 is
primarily active through oxygen-depletion
mechanisms implies that the intracellular oxygen
levels near the critical target(s) are different than
extracellular levels. Stated differently, one can
visualize the demonstrated cellular radiosensitivity
(Figure 3a) as being indicative of intracellular
oxygen tension at the critical target(s) for radiation
damage. The shift of these curves toward higher
oxygen tensions presumably indicates that the
intracellular oxygen tension at the critical target(s)
is lower than that in the extra-cellular medium. This
hypothesis can perhaps be appreciated more easily
by drawing an analogy with the spheroid system. In
large spheroids, even with air-equilibrated medium,
the rate of oxygen removal by the peripheral cells is
sufficient for some internal cells to be rendered
radiobiologically hypoxic. The same process must
occur in a single respiring cell: removal of oxygen
by the mitochondria (peripheral to the nucleus)
must make the nucleus differentially hypoxic. This
differential would, of course, be small, and thus
significant only at low extracellular oxygen tensions,
or if oxygen diffusion were impeded. Its impact
would, however, be increased by any agent which
lowered the extracellular oxygen tension, decreased
the oxygen diffusion rate, or increased the rate of
intracellular oxygen utilization.
Our conclusions are consistent with the results
reported for many systems in vivo. Harris andOXYGEN DEPENDENCE OF WR-2721 391
Phillips (1971) first noted the critical role of
oxygenation in WR-2721 protection, and recent
work by Denekamp et al. (1981, 1982) quantified
radioprotection of mouse skin as a function of
oxygen concentration in the inspired gas in a
manner qualitatively similar to the results reported
here. Lung, which should be one of the better-
oxygenated normal tissues, is only minimally
protected by WR-2721 (e.g. Yuhas, 1982).
Additionally, the apparent lack of protection of
tumours (at least for "cure-type" endpoints, where
response is determined by hypoxic cells) may be
entirely analogous to the minimal response we
observe for large spheroids.
An interesting corollary to the above arguments
develops, however, in view of the fact that the
protection factor observed for many normal tissues
in rodents is in the range of 2.0-3.0, i.e., in the same
range as the oxygen effect. If this protection can be
largely attributed to oxygen depletion by WR-2721,
it necessarily follows that most rodent normal
tissues may have a much poorer oxygen supply
than often assumed, in agreement with recent
observations by Hendry (1979). We are not aware,
however, of comparable data for human tissues.
The role of WR-2721 and other thiol agents in
chemoprotection is certainly not clarified by our
results, as drug-related toxicity (except for hypoxic
cell radiosensitizers) is not usually considered to be
highly oxygen-dependent. Our results may, however,
imply that radical scavenging and hydrogen
donation reactions may be more important for
drug-induced damage, or that additional effort
should be focussed on investigating potential
alterations in drug pharmacology in the presence of
WR-2721.
In addition to their implications regarding the
mechanisms of action of WR-2721, our results also
seem to address the location of the "protectable"
targets of the cell, and the role(s) of endogenous
thiols in radioresistance (e.g. Harris 1979; Cullen et
al., 1980). Oxygen removal (by thiol oxidation) may
be a common radioprotective mechanism. Thus,
depletion of cellular thiols would be expected to
have two radiosensitizing effects: an oxygen-
independent increase in sensitivity due to lack of
radical scavenging or hydrogen donating species,
and additionally, a shift of the curve relating
radiosensitivity and oxygen concentration toward
lower 02 levels, that is, closer equilibration between
intra- and extra-cellular oxygen tensions. This
would in turn produce a net increase in
radiosensitivity of thiol-depleted systems at low
oxygen concentrations. Thus, it may be difficult to
evaluate the mechanisms for radiosensitization
induced by thiol-depleting agents (e.g. Bump et al.,
1982) particularly in mixed oxygenation systems like
tumours or spheroids.
In summary, our initial experiments with
spheroids irradiated in the presence of WR-2721
showed that the degree of radioprotection observed
was dependent on spheroid size, and further,
suggested that WR-2721 acted largely as an oxygen-
depleting agent. A detailed examination of this
hypothesis using V79 single cells in suspension led
to results consistent with this interpretation.
Though the current results do not address the
critical question of tissue-dependent differences in
protector uptake or dephosphorylation, they do,
however, seem to provide a clear indication of the
nature of the radioprotection by WR-2721 that
might be expected in vivo.
I thank Drs. P.L. Olive, J.E. Biaglow and B.D. Michael
for helpful discussions during these studies, and Dr. J.W.
Purdie for providing his manuscript (1982) prior to its
publication. Support was provided by NCI Grant CA-
23511, DHHS.
References
BUMP, E.A., YU, N.Y. & BROWN, J.M. (1982).
Radiosensitization of hypoxic tumor cells by depletion
of intracellular glutathione. Science, 217, 544.
CULLEN, B.H., MICHALOWSKI, A. & WALKER, H.C.
(1980). Correlation between the radiobiological oxygen
constant, K, and the non-protein sulphydryl content of
mammalian cells. Int. J. Radiat. Biol., 38, 525.
DENEKAMP, J., MICHAEL, B.D., ROJAS, A. & STEWART,
F.A. (1982). Radioprotection of mouse skin by WR-
2721; the critical influence of oxygen. Int. J. Radiat.
Oncol. Biol. Phys., 8, 532.
DENEKAMP, J., MICHAEL, B.D., ROJAS, A. & STEWART,
F.A. (1981). Thiol radioprotection in vivo: the critical
role of tissue oxygen concentration. Br. J. Radiol., 54,
1112.
DURAND, R.E. (1980). Variable radiobiological responses
of spheroids. Radiat. Res., 81, 85.
HARRIS, J.W. (1979). Mammalian cell studies with
diamide. Pharmacol. Ther., 7, 375.
HARRIS, J.W. & PHILLIPS, T.L. (1971). Radiobiological
and biochemical studies of radioprotective compounds
related to cysteamine. Radiat. Res., 46, 362.
HENDRY, J.H. (1979). Quantitation of the
radiotherapeutic importance of naturally hypoxic
normal tissues from collated experiments with rodents
using single doses. Int. J. Radiat. Oncol. Biol. Phys., 5,
971.
KOLLMAN, G., YUHAS, J.M., LEONE, S. & SHAPIRO, B.
(1973). Mechanism of differential radiation protection
of tumor versus normal tissues by WR-2721 in tumor
bearing mice. Radiat. Res., 55, 603.
PHILLIPS, T.L. (1980). Rationale for initial clinical trials
and future development of radioprotectors. Cancer
Clin. Trials, 3, 165.392 R.E. DURAND
PURDIE, J.W. (1979). A comparative study of the
radioprotective effects of cysteamine, WR-2721, and
WR-1065 on cultured human cells. Radiat. Res., 77,
303.
PURDIE, J.W. (1980). Dephosphorylation of WR-2721 to
WR-1065 in vitro and effect of WR-1065 and
misonidazole in combination in irradiated cells. In
Radiation Sensitizers-Their Use in the Clinical
Management of Cancer (Ed. Brady) Masson, p 330.
PURDIE, J.W., INHABER, E.R., SCHNEIDER, H. &
LABELLE, J.L. (1982). Interaction of cultured
mammalian cells with WR-2721 and its thiol, WR-
1065: Implications for mechanisms of radioprotection.
Int. J. Radiat. Biol., (in press).
RITTER, M., BROWN, D.Q., GLOVER, D. & YUHAS, J.M.
(1982). In vitro studies on the absorption of WR-2721
by tumors and normal tissues. Int. J. Radiat. Oncol.
Biol. Phys., 8, 523.
SUTHERLAND, R.M. & DURAND, R.E. (1976). Radiation
response of multicell spheroids-an in vitro tumour
model. Curr. Topics Radiat. Res. Q., 11, 87.
UTLEY, J.F., MARLOWE, C. & WADDELL, W.J. (1976).
Distribution of 35-S labelled WR-2721 in normal and
malignant tissues of the mouse. Radiat. Res., 68, 284.
VOS, O., BUDKE, L. & GRANT, G.A. (1976). In vitro
evaluation of some latent radioprotective compounds.
Int. J. Radiat. Biol., 30, 433.
YUHAS, J.M. (1980). Active versus passive absorption
kinetics as the basis for selective protection of normal
tissues by S-2-(3-amino-propylamino)ethylphosphoro-
thioic acid. Cancer Res., 40, 1519.
YUHAS, J.M. (1982). Protective drugs in cancer therapy:
Optimal clinical testing and further development. Int.
J. Radiat. Oncol. Biol. Phys., 8, 513.